Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
13.96
+0.24 (1.75%)
Jan 22, 2026, 11:21 AM EST - Market open
Crescent Biopharma Market Cap
Crescent Biopharma has a market cap or net worth of $272.91 million as of January 22, 2026.
Market Cap
272.91M
Enterprise Value
270.94M
1-Year Change
n/a
Ranking
Category
Stock Price
$13.96
Market Cap Chart
Since June 16, 2025, Crescent Biopharma's market cap has decreased from $308.79M to $272.91M, a decrease of -11.62%. That is a compound annual growth rate of -18.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 268.22M | 15.68% |
| Dec 31, 2025 | 231.86M | -24.91% |
| Jun 16, 2025 | 308.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abeona Therapeutics | 287.76M |
| Aldeyra Therapeutics | 285.77M |
| Palisade Bio | 281.62M |
| Shattuck Labs | 274.63M |
| OmniAb | 274.24M |
| Avalo Therapeutics | 273.99M |
| Larimar Therapeutics | 273.89M |
| Neurogene | 271.38M |